2021 加拿大专家共识:难治性抑郁的定义、高危因素及评估

2021-02-02 国外精神科相关专家小组(统称) Depress Anxiety.2021 Feb 2. doi:10.1002/da.23135.

加拿大专家小组通过回顾现有证据及开展改良德尔菲法,围绕难治性抑郁(TRD)的概念、定义、分期、评估等撰写了最新专家共识。TRD严重损害患者的生活质量及功能水平,造成沉重的医疗及社会负担。

中文标题:

2021 加拿大专家共识:难治性抑郁的定义、高危因素及评估

英文标题:

Treatment-resistant major depressive disorder: Canadian expert consensus on definition and assessment

发布日期:

2021-02-02

简要介绍:

加拿大专家小组通过回顾现有证据及开展改良德尔菲法,围绕难治性抑郁(TRD)的概念、定义、分期、评估等撰写了最新专家共识。TRD严重损害患者的生活质量及功能水平,造成沉重的医疗及社会负担。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=021 加拿大专家共识:难治性抑郁的定义、高危因素及评.pdf)] GetToolGuiderByIdResponse(projectId=1, id=d71d41c0020ea445, title=2021 加拿大专家共识:难治性抑郁的定义、高危因素及评估, enTitle=Treatment-resistant major depressive disorder: Canadian expert consensus on definition and assessment, guiderFrom=Depress Anxiety.2021 Feb 2. doi:10.1002/da.23135., authorId=0, author=, summary=加拿大专家小组通过回顾现有证据及开展改良德尔菲法,围绕难治性抑郁(TRD)的概念、定义、分期、评估等撰写了最新专家共识。TRD严重损害患者的生活质量及功能水平,造成沉重的医疗及社会负担。, cover=https://img.medsci.cn/2021328/1616861080089_2020535.jpg, journalId=0, articlesId=null, associationId=1320, associationName=国外精神科相关专家小组(统称), associationIntro=, copyright=0, guiderPublishedTime=Tue Feb 02 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>加拿大专家小组通过回顾现有证据及开展改良德尔菲法,围绕难治性抑郁(TRD)的概念、定义、分期、评估等撰写了最新专家共识。TRD严重损害患者的生活质量及功能水平,造成沉重的医疗及社会负担。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=228, tagName=抑郁症)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1273, guiderKeyword=抑郁, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10047, appHits=135, showAppHits=0, pcHits=765, showPcHits=9912, likes=0, shares=9, comments=14, approvalStatus=1, publishedTime=Sun Mar 28 00:59:20 CST 2021, publishedTimeString=2021-02-02, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Mar 28 00:04:45 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 10:31:28 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=021 加拿大专家共识:难治性抑郁的定义、高危因素及评.pdf)])
021 加拿大专家共识:难治性抑郁的定义、高危因素及评.pdf
下载请点击:
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1065065, encodeId=b37d10650654e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7545624945, createdName=ms2000002071476021, createdTime=Fri Oct 29 19:10:49 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062372, encodeId=030b10623e2c6, content=非常喜欢的内容,非常好的共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/7274ed1be4747d648e4e2f7f62fae403.jpg, createdBy=d8d65273314, createdName=1482963am12暂无昵称, createdTime=Wed Oct 20 20:35:56 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058587, encodeId=1080105858e93, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fec2067476, createdName=特立独行的红猪, createdTime=Fri Oct 08 12:58:12 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014854, encodeId=1b8a101485454, content=难治性抑郁,当前优选推荐怎样的用药方案,有没有国外最前沿但国内还没有的药物呢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459d5467529, createdName=ms1000000580800231, createdTime=Sun Sep 05 21:30:36 CST 2021, time=2021-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011409, encodeId=d32d101140937, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbd15570111, createdName=ms5000000793547615, createdTime=Wed Aug 25 16:32:24 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
    2021-10-29 ms2000002071476021

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1065065, encodeId=b37d10650654e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7545624945, createdName=ms2000002071476021, createdTime=Fri Oct 29 19:10:49 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062372, encodeId=030b10623e2c6, content=非常喜欢的内容,非常好的共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/7274ed1be4747d648e4e2f7f62fae403.jpg, createdBy=d8d65273314, createdName=1482963am12暂无昵称, createdTime=Wed Oct 20 20:35:56 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058587, encodeId=1080105858e93, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fec2067476, createdName=特立独行的红猪, createdTime=Fri Oct 08 12:58:12 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014854, encodeId=1b8a101485454, content=难治性抑郁,当前优选推荐怎样的用药方案,有没有国外最前沿但国内还没有的药物呢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459d5467529, createdName=ms1000000580800231, createdTime=Sun Sep 05 21:30:36 CST 2021, time=2021-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011409, encodeId=d32d101140937, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbd15570111, createdName=ms5000000793547615, createdTime=Wed Aug 25 16:32:24 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
    2021-10-20 1482963am12暂无昵称

    非常喜欢的内容,非常好的共识

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1065065, encodeId=b37d10650654e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7545624945, createdName=ms2000002071476021, createdTime=Fri Oct 29 19:10:49 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062372, encodeId=030b10623e2c6, content=非常喜欢的内容,非常好的共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/7274ed1be4747d648e4e2f7f62fae403.jpg, createdBy=d8d65273314, createdName=1482963am12暂无昵称, createdTime=Wed Oct 20 20:35:56 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058587, encodeId=1080105858e93, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fec2067476, createdName=特立独行的红猪, createdTime=Fri Oct 08 12:58:12 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014854, encodeId=1b8a101485454, content=难治性抑郁,当前优选推荐怎样的用药方案,有没有国外最前沿但国内还没有的药物呢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459d5467529, createdName=ms1000000580800231, createdTime=Sun Sep 05 21:30:36 CST 2021, time=2021-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011409, encodeId=d32d101140937, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbd15570111, createdName=ms5000000793547615, createdTime=Wed Aug 25 16:32:24 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
    2021-10-08 特立独行的红猪

    学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1065065, encodeId=b37d10650654e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7545624945, createdName=ms2000002071476021, createdTime=Fri Oct 29 19:10:49 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062372, encodeId=030b10623e2c6, content=非常喜欢的内容,非常好的共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/7274ed1be4747d648e4e2f7f62fae403.jpg, createdBy=d8d65273314, createdName=1482963am12暂无昵称, createdTime=Wed Oct 20 20:35:56 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058587, encodeId=1080105858e93, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fec2067476, createdName=特立独行的红猪, createdTime=Fri Oct 08 12:58:12 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014854, encodeId=1b8a101485454, content=难治性抑郁,当前优选推荐怎样的用药方案,有没有国外最前沿但国内还没有的药物呢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459d5467529, createdName=ms1000000580800231, createdTime=Sun Sep 05 21:30:36 CST 2021, time=2021-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011409, encodeId=d32d101140937, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbd15570111, createdName=ms5000000793547615, createdTime=Wed Aug 25 16:32:24 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
    2021-09-05 ms1000000580800231

    难治性抑郁,当前优选推荐怎样的用药方案,有没有国外最前沿但国内还没有的药物呢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1065065, encodeId=b37d10650654e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7545624945, createdName=ms2000002071476021, createdTime=Fri Oct 29 19:10:49 CST 2021, time=2021-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062372, encodeId=030b10623e2c6, content=非常喜欢的内容,非常好的共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/7274ed1be4747d648e4e2f7f62fae403.jpg, createdBy=d8d65273314, createdName=1482963am12暂无昵称, createdTime=Wed Oct 20 20:35:56 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058587, encodeId=1080105858e93, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fec2067476, createdName=特立独行的红猪, createdTime=Fri Oct 08 12:58:12 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014854, encodeId=1b8a101485454, content=难治性抑郁,当前优选推荐怎样的用药方案,有没有国外最前沿但国内还没有的药物呢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459d5467529, createdName=ms1000000580800231, createdTime=Sun Sep 05 21:30:36 CST 2021, time=2021-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011409, encodeId=d32d101140937, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbd15570111, createdName=ms5000000793547615, createdTime=Wed Aug 25 16:32:24 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
    2021-08-25 ms5000000793547615

    学习

    0

拓展阅读

2009 NICE 成年人抑郁症的治疗与管理

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2009-10-28

2009 NICE 对有抑郁症与慢性健康问题成年人的治疗和管理指南

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2009-11-01

2010英属哥伦比亚卫生部儿童和青少年焦虑和抑郁的诊断和治疗指南

英属哥伦比亚卫生部(Ministry of Health (British Columbia)) · 2010-01-01

成人抑郁症非药物治疗指南

苏格兰校际指南网络(SIGN,Scottish Intercollegiate Guidelines Network) · 2010-01-01

2010AAP 美国围产期和产后抑郁症的临床识别与治疗:临床报告

美国儿科学会(AAP,American Academy of Pediatrics) · 2010-01-01

世界生物精神病学学会联合会(WFSBP)双相障碍生物学治疗指南:2010年双相急性抑郁发作治疗更新

世界生物精神病学会联合会(WFSBP,World Federation of Societies of Biological Psychiatry) · 2010-03-01